Detalhe da pesquisa
1.
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Blood
; 139(8): 1208-1221, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482403
2.
Functional genomic landscape of acute myeloid leukaemia.
Nature
; 562(7728): 526-531, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333627
3.
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 117(25): 14331-14341, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513686
4.
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
Blood
; 133(6): 588-599, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425048
5.
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Blood
; 134(11): 867-879, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366621
6.
CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia.
Br J Haematol
; 202(1): 195-198, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182843
7.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Front Immunol
; 15: 1297338, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38495876
8.
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.
Cell Rep Med
; 5(1): 101359, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232702
9.
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.
Blood Cancer J
; 13(1): 59, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088803
10.
Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia.
Front Oncol
; 13: 1192829, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37361575
11.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Blood Adv
; 7(9): 1899-1909, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441905
12.
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.
Blood Cancer Discov
; 4(6): 452-467, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698624
13.
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.
Mol Cancer Res
; 21(7): 631-647, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36976323
14.
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.
Blood Adv
; 6(10): 3062-3067, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078224
15.
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell
; 40(8): 850-864.e9, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868306
16.
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.
Leukemia
; 34(9): 2342-2353, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094466
17.
Two myeloid leukemia cases with rare FLT3 fusions.
Cold Spring Harb Mol Case Stud
; 4(6)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559310
18.
Not your average birth: considering the possibility of denied or concealed pregnancy.
BMJ Case Rep
; 20142014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24876214